Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Everest Medical

This article was originally published in The Gray Sheet

Executive Summary

Receives $800,000 equity investment from a private investor through the sale of 290,909 units at $2.75 each. The units consist of one share of unregistered common stock and one warrant to purchase a share of unregistered common stock for $3.50. The company had announced Jan. 21 that it was seeking financing from "numerous corporate and private sources" to continue operations ("The Gray Sheet" Feb. 1, p. 14). Everest Medical Chairman Michael Hollenhorst says in a Feb. 8 release that the recent investment "provides us with necessary working capital which will help us to cover operating expenses as we roll out our laparoscopic surgical scissors and forceps." The company "will require additional capital, which is being sought from various sources." The minimally invasive surgery products manufacturer says it has taken steps to "further reduce" its operating expenses and expects to make "additional spending and staff reductions." The company believes the reductions can be made "without significantly jeopardizing" sales and development activities. The firm also announced Feb. 8 that it has received notice from its Japanese distributor, Koshin International, that Japan's Ministry of Health has granted approval for Koshin to commence promotion and sales of Everest Medical's Evershears bipolar laparoscopic scissors in Japan.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT000198

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel